Even as Johnson & Johnson’s oncology superstar Darzalex Faspro racks up megablockbuster sales and reshapes the multiple ...

"Detect the SOS is a multi-stakeholder movement that brings together trusted voices, advocates, healthcare professionals and ...

With Cellares preparing to begin commercial-stage production in 2027, the California-based cell therapy contract manufacturer has taken a major step toward that goal, ...

About 1.8 million people used one or more of the 15 drugs through Medicare Part D or Part B between November 2024 and October 2025, the CMS said. The batch of 15 meds accounted for about $27 billion ...

After posting 16.2% revenue growth in the last financial year, Servier President Olivier Laureau said the company has moved ...

Regulatory authorities in China have cracked down on Sun Pharma’s rivastigmine-based Alzheimer’s disease treatment, halting ...

The drugmaker has recruited Will Forte, who appeared on “SNL” for nearly a decade in the aughts, perhaps most memorably as ...

But while the rankings held steady, the operating environment has changed quickly to reinforce the value of being in good standing with physicians.

Catalent made a series of deals early this decade to build up its presence in Gosselies. Now, it's planning to wind down cell ...

Swiss CDMO Sigfried has been on a growth jag over the last decade. | Siegfried has signed agreements to acquire the controlled drug substance businesses of the Noramco Group and Extractas Bioscience.

Arcutis Biotherapeutics and Kowa Pharmaceuticals are cutting ties on their U.S. marketing partnership around Arcutis’ Zoryve ...

The new chairman of the CDC's Advisory Committee on Immunization Practices, Kirk Milhoan, M.D., Ph.D., recently took to the ...